JUBILANT DRAXIMAGE RADIOPHARMACIES INC., operating as Triad Isotopes, is a specialized pharmaceutical company focused on nuclear medicine and radiopharmaceutical products. The company operates as a network of radiopharmacies across the United States, providing nuclear medicine products and services to hospitals, clinics, and imaging centers. The company was originally established as Triad Isotopes before being acquired by Jubilant DraxImage, a subsidiary of Jubilant Life Sciences. The acquisition expanded Jubilant’s presence in the North American radiopharmacy market. The company specializes in the preparation and distribution of radiopharmaceuticals, which are radioactive drugs used in nuclear medicine procedures for both diagnostic imaging and therapeutic purposes. Their services include the compounding and dispensing of patient-specific radiopharmaceutical doses, quality control testing, and radioactive material handling. The company maintains strict compliance with Nuclear Regulatory Commission (NRC) regulations and follows USP guidelines for radiopharmaceutical preparation. Their network of pharmacies operates on a 24/7 basis to accommodate emergency orders and time-sensitive deliveries, given the short half-life of many radiopharmaceutical products. The company’s headquarters is located in Montreal, Quebec, Canada, while its radiopharmacy operations are distributed throughout various locations in the United States.